Seattle Genetics Eliminates $2 Billion Deal With Immunomedics
May 06, 2017 at 14:39 PM EDT
On Friday, it was announced that Seattle Genetics had ended a potential $2 billion deal with Immunomedics. The initial deal was proposed back in February of this year.
